Difficulty: Medium
Average Score: 75%
Practice
Which of the following medications has the most potential to significantly impair the ability to drive an automobile?
Correct answer
C
Rationale
In the context of Lifespan Pharmacology, understanding the effects of medications on driving ability is crucial for patient safety. The correct answer is C) Diphenhydramine. Diphenhydramine is a first-generation antihistamine that readily crosses the blood-brain barrier, leading to central nervous system depression and sedation. These effects can impair cognitive and motor functions necessary for safe driving, making it the medication with the most potential to significantly impair driving ability.
Option A) Ranitidine is a histamine-2 blocker used to reduce stomach acid production and is unlikely to cause significant CNS depression or sedation, thus less likely to impair driving.
Option B) Levocetirizine is a second-generation antihistamine with a low likelihood of CNS side effects due to its reduced ability to cross the blood-brain barrier. It is considered non-sedating and is less likely to impair driving compared to diphenhydramine.
Option D) Fexofenadine is also a second-generation antihistamine, known for its non-sedating properties. Like levocetirizine, it has a lower risk of impairing driving ability compared to diphenhydramine.
Educationally, this question highlights the importance of considering the potential side effects of medications, especially those affecting the CNS, when assessing a patient's ability to perform tasks such as driving safely. Understanding the pharmacological properties of different medications can help healthcare providers make informed decisions to promote patient well-being and public safety.
Option A) Ranitidine is a histamine-2 blocker used to reduce stomach acid production and is unlikely to cause significant CNS depression or sedation, thus less likely to impair driving.
Option B) Levocetirizine is a second-generation antihistamine with a low likelihood of CNS side effects due to its reduced ability to cross the blood-brain barrier. It is considered non-sedating and is less likely to impair driving compared to diphenhydramine.
Option D) Fexofenadine is also a second-generation antihistamine, known for its non-sedating properties. Like levocetirizine, it has a lower risk of impairing driving ability compared to diphenhydramine.
Educationally, this question highlights the importance of considering the potential side effects of medications, especially those affecting the CNS, when assessing a patient's ability to perform tasks such as driving safely. Understanding the pharmacological properties of different medications can help healthcare providers make informed decisions to promote patient well-being and public safety.